Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Abbas Hassan, Abid Hussain Khan, Faiza Saleem, Haseen Ahmad & Khalid Mohammed Khan. (2022) A patent review of pharmaceutical and therapeutic applications of oxadiazole derivatives for the treatment of chronic diseases (2013–2021). Expert Opinion on Therapeutic Patents 32:9, pages 969-1001.
Read now
Read now
Alastair L. Parkes & Ian A. Yule. (2016) Hybrid antibiotics – clinical progress and novel designs. Expert Opinion on Drug Discovery 11:7, pages 665-680.
Read now
Read now
Premkumar Jayaraman, Kishore R Sakharkar, ChuSing Lim, Mohammad Imran Siddiqi, Sarinder K Dhillon & Meena K Sakharkar. (2013) Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR. Drug Design, Development and Therapy 7, pages 449-475.
Read now
Read now
Stephen P East & Lynn L Silver. (2013) Multitarget ligands in antibacterial research: progress and opportunities. Expert Opinion on Drug Discovery 8:2, pages 143-156.
Read now
Read now
Articles from other publishers (84)
Hamada H. H. Mohammed, Doaa Mohamed Elroby Ali, Mohamed Badr, Ahmed G. K. Habib, Abobakr Mohamed Mahmoud, Sarah M. Farhan, Shimaa Salah Hassan Abd El Gany, Soad A. Mohamad, Alaa M. Hayallah, Samar H. Abbas & Gamal El-Din A. Abuo-Rahma. (2022) Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors. Molecular Diversity 27:4, pages 1751-1765.
Crossref
Crossref
Augustine Jing Jie Koh, Varsha Thombare, Maytham Hussein, Gauri G. Rao, Jian Li & Tony Velkov. (2023) Bifunctional antibiotic hybrids: A review of clinical candidates. Frontiers in Pharmacology 14.
Crossref
Crossref
Pavel N. Solyev, Elena B. Isakova & Evgenia N. Olsufyeva. (2023) Antibacterial Conjugates of Kanamycin A with Vancomycin and Eremomycin: Biological Activity and a New MS-Fragmentation Pattern of Cbz-Protected Amines. Antibiotics 12:5, pages 894.
Crossref
Crossref
Jonathan I. Batchelder, Patricia J. Hare & Wendy W. K. Mok. (2023) Resistance-resistant antibacterial treatment strategies. Frontiers in Antibiotics 2.
Crossref
Crossref
Sarfraz Ahmed, Muhammad Zeeshan Ahmed, Safa Rafique, Seham Eid Almasoudi, Mohibullah Shah, Nur Asyilla Che Jalil & Suvash Chandra Ojha. (2023) Recent Approaches for Downplaying Antibiotic Resistance: Molecular Mechanisms. BioMed Research International 2023, pages 1-27.
Crossref
Crossref
Bilal Aslam, Moeed Ahmad, Muhammad Usama Tariq, Saima Muzammil, Abu Baker Siddique, Mohsin Khurshid, Aqsa Shahid, Muhammad Hidayat Rasool, Tamoor Hamid Chaudhry, Afreenish Amir, Muhammad Salman & Zulqarnain Baloch. 2023. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources
1
37
.
Luofeng Yu, Zifang Shang, Qizhe Jin, Siew Yin Chan, Weilin Hong, Nan Li & Peng Li. (2022) Antibody–Antimicrobial Conjugates for Combating Antibiotic Resistance. Advanced Healthcare Materials 12:1.
Crossref
Crossref
V. V. Belakhov. (2023) Polyfunctional Drugs: Search, Development, Use in Medical Practice, and Environmental Aspects of Preparation and Application (A Review). Russian Journal of General Chemistry 92:13, pages 3030-3055.
Crossref
Crossref
Augustine Koh Jing Jie, Maytham Hussein, Gauri G. Rao, Jian Li & Tony Velkov. (2022) Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations. Pathogens 11:12, pages 1420.
Crossref
Crossref
Ioana-Andreea Lungu, Octavia-Laura Moldovan, Victoria Biriș & Aura Rusu. (2022) Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance. Pharmaceutics 14:8, pages 1749.
Crossref
Crossref
Emma van Groesen, Paolo Innocenti & Nathaniel I. Martin. (2022) Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022. ACS Infectious Diseases 8:8, pages 1381-1407.
Crossref
Crossref
Hossameldin A. Aziz, Ahmed M. M. El-Saghier, Mohamed Badr, Gamal El-Din A. Abuo-Rahma & Mai E. Shoman. (2021) Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities. Molecular Diversity 26:3, pages 1743-1759.
Crossref
Crossref
Zintle Mbese, Margo Nell, Youmbi T. Fonkui, Derek T. Ndinteh, Vanessa Steenkamp & Blessing A. Aderibigbe. (2022) Hybrid Compounds Containing Carvacrol Scaffold: In Vitro
Antibacterial and Cytotoxicity Evaluation. Recent Advances in Anti-Infective Drug Discovery 17:1, pages 54-68.
Crossref
Crossref
Fatma Albayrak, Mustafa Çiçek, Deniz Alkaya & Irem Kulu. (2022) Design, synthesis and biological evaluation of 8-aminoquinoline-1,2,3-triazole hybrid derivatives as potential antimicrobial agents. Medicinal Chemistry Research 31:4, pages 652-665.
Crossref
Crossref
Noha M. Ibrahim, Samar H. Fahim, Mariam Hassan, Awatef E. Farag & Hanan H. Georgey. (2022) Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects. European Journal of Medicinal Chemistry 228, pages 114021.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
343
374
.
Hongfei Jiang, Xiaofei Qin, Qi Wang, Qi Xu, Jie Wang, Yudong Wu, Wujun Chen, Chao Wang, Tingting Zhang, Dongming Xing & Renshuai Zhang. (2021) Application of carbohydrates in approved small molecule drugs: A review. European Journal of Medicinal Chemistry 223, pages 113633.
Crossref
Crossref
Matt D. Johansen, Shalini, Sumit Kumar, Clément Raynaud, Diana H. Quan, Warwick J. Britton, Philip M. Hansbro, Vipan Kumar & Laurent Kremer. (2021)
Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against
Mycobacterium tuberculosis
. Antimicrobial Agents and Chemotherapy 65:8.
Crossref
Crossref
Meilin Zhu, Megan W. Tse, Juliane Weller, Julie Chen & Paul C. Blainey. (2021) The future of antibiotics begins with discovering new combinations. Annals of the New York Academy of Sciences 1496:1, pages 82-96.
Crossref
Crossref
Abdrrahman Shemsu Surur & Dianqing Sun. (2021) Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates. Frontiers in Chemistry 9.
Crossref
Crossref
Julia A. Pavlova, Zimfira Z. Khairullina, Andrey G. Tereshchenkov, Pavel A. Nazarov, Dmitrii A. Lukianov, Inna A. Volynkina, Dmitry A. Skvortsov, Gennady I. Makarov, Etna Abad, Somay Y. Murayama, Susumu Kajiwara, Alena Paleskava, Andrey L. Konevega, Yuri N. Antonenko, Alex Lyakhovich, Ilya A. Osterman, Alexey A. Bogdanov & Natalia V. Sumbatyan. (2021) Triphenilphosphonium Analogs of Chloramphenicol as Dual-Acting Antimicrobial and Antiproliferating Agents. Antibiotics 10:5, pages 489.
Crossref
Crossref
Qais Z. Jaber & Micha Fridman. (2021) Fresh Molecular Concepts to Extend the Lifetimes of Old Antimicrobial Drugs. The Chemical Record 21:4, pages 631-645.
Crossref
Crossref
Moshe N. Goldmeier, Sofya Katz, Fabian Glaser, Valery Belakhov, Alina Khononov & Timor Baasov. (2021) Toward Catalytic Antibiotics: Redesign of Fluoroquinolones to Catalytically Fragment Chromosomal DNA. ACS Infectious Diseases 7:3, pages 608-623.
Crossref
Crossref
Dorota Kowalczuk, Agata Gładysz, Monika Pitucha, Daniel M. Kamiński, Agnieszka Barańska & Bartłomiej Drop. (2021) Spectroscopic Study of the Molecular Structure of the New Hybrid with a Potential Two-Way Antibacterial Effect. Molecules 26:5, pages 1442.
Crossref
Crossref
Harish C. Upadhyay. (2021) Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance. Current Topics in Medicinal Chemistry 21:8, pages 737-752.
Crossref
Crossref
Mousumi Shyam, Deepak Shilkar, Harshita Verma, Abhimanyu Dev, Barij Nayan Sinha, Federico Brucoli, Sanjib BhaktaVenkatesan Jayaprakash. (2020) The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis. Journal of Medicinal Chemistry 64:1, pages 71-100.
Crossref
Crossref
John BremnerJohn Bremner. 2021. Multiple Action-Based Design Approaches to Antibacterials. Multiple Action-Based Design Approaches to Antibacterials
51
119
.
Andrea Dorst, Regina Berg, Christoph G. W. Gertzen, Daniel Schäfle, Katja Zerbe, Myriam Gwerder, Simon D. Schnell, Peter Sander, Holger Gohlke & Karl Gademann. (2020) Semisynthetic Analogs of the Antibiotic Fidaxomicin—Design, Synthesis, and Biological Evaluation. ACS Medicinal Chemistry Letters 11:12, pages 2414-2420.
Crossref
Crossref
Parteek Prasher, Mousmee Sharma, Alaa A. A. Aljabali, Gaurav Gupta, Poonam Negi, Deepak N. Kapoor, Inderbir Singh, Flavia C. Zacconi, Terezinha Jesus Andreoli Pinto, Mateus Webba Silva, Hamid A. Bakshi, Dinesh Kumar Chellappan, Murtaza M. Tambuwala & Kamal Dua. (2020) Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review. Drug Development Research 81:7, pages 837-858.
Crossref
Crossref
Sarka Pospisilova, Ivan Malik, Jana Curillova, Hana Michnova, Lucie Cerna, Tereza Padrtova, Jan Hosek, Daniel Pecher, Alois Cizek & Josef Jampilek. (2020) Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols. Bioorganic Chemistry 102, pages 104060.
Crossref
Crossref
John Chu, Bimal Koirala, Nicholas Forelli, Xavier Vila-Farres, Melinda A. Ternei, Thahmina Ali, Dominic A. Colosimo & Sean F. Brady. (2020) Synthetic-Bioinformatic Natural Product Antibiotics with Diverse Modes of Action. Journal of the American Chemical Society 142:33, pages 14158-14168.
Crossref
Crossref
Declan Alan Gray & Michaela Wenzel. (2020) Multitarget Approaches against Multiresistant Superbugs. ACS Infectious Diseases 6:6, pages 1346-1365.
Crossref
Crossref
Alexey Yurjevich Lukin, Tatiana Sergeevna Vedekhina & Mikhail Vassiljevich Chudinov. (2020) 5-Nitrofuran-2-yl Thiohydrazones as Double Antibacterial Agents Synthesis and In Vitro Evaluation. Letters in Drug Design & Discovery 17:3, pages 356-361.
Crossref
Crossref
Zifang Shang, Siew Yin Chan, Qing Song, Peng Li & Wei Huang. (2020) The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance. Research 2020.
Crossref
Crossref
Duy-Khiet Ho, Brittany L.B. Nichols, Kevin J. Edgar, Xabier Murgia, Brigitta Loretz & Claus-Michael Lehr. (2019) Challenges and strategies in drug delivery systems for treatment of pulmonary infections. European Journal of Pharmaceutics and Biopharmaceutics 144, pages 110-124.
Crossref
Crossref
Mubarak H. Shaikh, Dnyaneshwar D. Subhedar, Laxman Nawale, Dhiman Sarkar, Firoz A. Kalam Khan, Jaiprakash N. Sangshetti & Bapurao B. Shingate. (2019) Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking. Mini-Reviews in Medicinal Chemistry 19:14, pages 1178-1194.
Crossref
Crossref
Naphak Modhiran, Neha S. Gandhi, Norbert Wimmer, Stacey Cheung, Katryn Stacey, Paul R. Young, Vito Ferro & Daniel Watterson. (2019) Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545. Antiviral Research 168, pages 121-127.
Crossref
Crossref
Xueqian Bai, Ying Chen, Zhe Liu, Linhao Zhang, Tianyi Zhang & Bo Feng. (2019) Synthesis, Antimicrobial Activities, and Molecular Docking Studies of Dihydrotriazine Derivatives Bearing a Quinoline Moiety. Chemistry & Biodiversity.
Crossref
Crossref
Liu, Shao, Li, Cui, Li, Zhou, Lv & Zhang. (2019) Synthesis, Antibacterial Activities, Mode of Action and Acute Toxicity Studies of New Oxazolidinone-Fluoroquinolone Hybrids. Molecules 24:8, pages 1641.
Crossref
Crossref
Anna N. Tevyashova, Alexander M. Korolev, Elena P. Mirchink, Elena B. Isakova & Ilya A. Osterman. (2018) Synthesis and evaluation of biological activity of benzoxaborole derivatives of azithromycin. The Journal of Antibiotics 72:1, pages 22-33.
Crossref
Crossref
Anna N. Tevyashova, Elena N. Bychkova, Alexander M. Korolev, Elena B. Isakova, Elena P. Mirchink, Ilya A. Osterman, Réka Erdei, Zsolt Szücs & Gyula Batta. (2019) Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides. Bioorganic & Medicinal Chemistry Letters 29:2, pages 276-280.
Crossref
Crossref
Feng Gao, Peng Wang, Hua Yang, Qing Miao, Long Ma & Guangming Lu. (2018) Recent developments of quinolone-based derivatives and their activities against Escherichia coli. European Journal of Medicinal Chemistry 157, pages 1223-1248.
Crossref
Crossref
Hend A. A. Ezelarab, Samar H. Abbas, Heba A. Hassan & Gamal El-Din A. Abuo-Rahma. (2018) Recent updates of fluoroquinolones as antibacterial agents. Archiv der Pharmazie 351:9, pages 1800141.
Crossref
Crossref
Ronald Domalaon, Temilolu Idowu, George G. Zhanel & Frank Schweizer. (2018) Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?. Clinical Microbiology Reviews 31:2.
Crossref
Crossref
Yun-Ta Lee, Feng-Yu Chiu, Indrajeet J. Barve & Chung-Ming Sun. (2018)
Microwave-Assisted Synthesis of Benzimidazole-Linked Indoline and Indole Hybrids from C-2 Linked (
o
-Aminobenzyl)benzimidazoles
. Advanced Synthesis & Catalysis 360:3, pages 502-512.
Crossref
Crossref
Sandra Zárate, M. De la Cruz Claure, Raúl Benito-Arenas, Julia Revuelta, Andrés Santana & Agatha Bastida. (2018) Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors. Molecules 23:2, pages 284.
Crossref
Crossref
Ronald Domalaon, Xuan Yang, Yinfeng Lyu, George G. Zhanel & Frank Schweizer. (2017)
Polymyxin B
3
–Tobramycin Hybrids with
Pseudomonas aeruginosa
-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin
. ACS Infectious Diseases 3:12, pages 941-954.
Crossref
Crossref
Yuan-Qiang Hu, Shu Zhang, Zhi Xu, Zao-Sheng Lv, Ming-Liang Liu & Lian-Shun Feng. (2017) 4-Quinolone hybrids and their antibacterial activities. European Journal of Medicinal Chemistry 141, pages 335-345.
Crossref
Crossref
Michal Shavit, Varvara Pokrovskaya, Valery Belakhov & Timor Baasov. (2017) Covalently linked kanamycin – Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance. Bioorganic & Medicinal Chemistry 25:11, pages 2917-2925.
Crossref
Crossref
Jeong Sang Yi, Min Woo Kim, Minsuk Kim, Yujin Jeong, Eun-Jung Kim, Byung-Kwan Cho & Byung-Gee Kim. (2016)
A Novel Approach for Gene Expression Optimization through Native Promoter and 5′ UTR Combinations Based on RNA-seq, Ribo-seq, and TSS-seq of
Streptomyces coelicolor
. ACS Synthetic Biology 6:3, pages 555-565.
Crossref
Crossref
Erika van Eijk, Bert Wittekoek, Ed J. Kuijper & Wiep Klaas Smits. (2017) DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. Journal of Antimicrobial Chemotherapy, pages dkw548.
Crossref
Crossref
P. Klahn & M. Brönstrup. (2017) Bifunctional antimicrobial conjugates and hybrid antimicrobials. Natural Product Reports 34:7, pages 832-885.
Crossref
Crossref
Bala Kishan Gorityala, Goutam Guchhait, Sudeep Goswami, Dinesh M. Fernando, Ayush Kumar, George G. Zhanel & Frank Schweizer. (2016)
Hybrid Antibiotic Overcomes Resistance in
P. aeruginosa
by Enhancing Outer Membrane Penetration and Reducing Efflux
. Journal of Medicinal Chemistry 59:18, pages 8441-8455.
Crossref
Crossref
Hannah Ulm & Tanja Schneider. (2016) Targeting bactoprenol-coupled cell envelope precursors. Applied Microbiology and Biotechnology 100:18, pages 7815-7825.
Crossref
Crossref
Zhenkun Ma & Anthony Simon Lynch. (2016) Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections. Journal of Medicinal Chemistry 59:14, pages 6645-6657.
Crossref
Crossref
Kathy K. Wang, Laura K. Stone, Tami D. Lieberman, Michal Shavit, Timor Baasov & Roy Kishony. (2016) A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway. Molecular Biology and Evolution 33:2, pages 492-500.
Crossref
Crossref
Bala Kishan Gorityala, Goutam Guchhait, Dinesh M. Fernando, Soumya Deo, Sean A. McKenna, George G. Zhanel, Ayush Kumar & Frank Schweizer. (2016)
Adjuvants Based on Hybrid Antibiotics Overcome Resistance in
Pseudomonas aeruginosa
and Enhance Fluoroquinolone Efficacy
. Angewandte Chemie International Edition 55:2, pages 555-559.
Crossref
Crossref
Bala Kishan Gorityala, Goutam Guchhait, Dinesh M. Fernando, Soumya Deo, Sean A. McKenna, George G. Zhanel, Ayush Kumar & Frank Schweizer. (2016)
Adjuvants Based on Hybrid Antibiotics Overcome Resistance in
Pseudomonas aeruginosa
and Enhance Fluoroquinolone Efficacy
. Angewandte Chemie 128:2, pages 565-569.
Crossref
Crossref
Michael BaymLaura K. StoneRoy Kishony. (2016) Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351:6268.
Crossref
Crossref
Ramdayal Yadav & Kandasubramanian Balasubramanian. 2016. Engineering of Nanobiomaterials. Engineering of Nanobiomaterials
77
117
.
Siva S. Panda, Sumaira Liaqat, Adel S. Girgis, Ahmed Samir, C. Dennis Hall & Alan R. Katritzky. (2015) Novel antibacterial active quinolone–fluoroquinolone conjugates and 2D-QSAR studies. Bioorganic & Medicinal Chemistry Letters 25:18, pages 3816-3821.
Crossref
Crossref
Audrey G. Ross, Bret M. Benton, Donovan Chin, Gianfranco De Pascale, John Fuller, Jennifer A. Leeds, Folkert Reck, Daryl L. Richie, Jason Vo & Matthew J. LaMarche. (2015) Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space. Bioorganic & Medicinal Chemistry Letters 25:17, pages 3468-3475.
Crossref
Crossref
Zachary D. Dunn, Walter J. Wever, Nicoleta J. Economou, Albert A. Bowers & Bo Li. (2015) Enzymatic Basis of “Hybridity” in Thiomarinol Biosynthesis. Angewandte Chemie International Edition 54:17, pages 5137-5141.
Crossref
Crossref
Zachary D. Dunn, Walter J. Wever, Nicoleta J. Economou, Albert A. Bowers & Bo Li. (2015) Enzymatic Basis of “Hybridity” in Thiomarinol Biosynthesis. Angewandte Chemie 127:17, pages 5226-5230.
Crossref
Crossref
A N Tevyashova, E N Olsufyeva & M N Preobrazhenskaya. (2015) Design of dual action antibiotics as an approach to search for new promising drugs. Russian Chemical Reviews 84:1, pages 61-97.
Crossref
Crossref
Agnieszka E. Bem, Nadya Velikova, M. Teresa Pellicer, Peter van Baarlen, Alberto Marina & Jerry M. Wells. (2014) Bacterial Histidine Kinases as Novel Antibacterial Drug Targets. ACS Chemical Biology 10:1, pages 213-224.
Crossref
Crossref
Molly A. Silvers, Gregory T. Robertson, Carol M. Taylor & Grover L. Waldrop. (2014) Design, Synthesis, and Antibacterial Properties of Dual-Ligand Inhibitors of Acetyl-CoA Carboxylase. Journal of Medicinal Chemistry 57:21, pages 8947-8959.
Crossref
Crossref
Mamun-Ur Rashid, Axel Dalhoff, Tobias Bäckström, Linda Björkhem-Bergman, Georgios Panagiotidis, Andrej Weintraub & Carl Erik Nord. (2014) Ecological impact of MCB3837 on the normal human microbiota. International Journal of Antimicrobial Agents 44:2, pages 125-130.
Crossref
Crossref
Mamun-Ur Rashid, Axel Dalhoff, Andrej Weintraub & Carl Erik Nord. (2014) In vitro activity of MCB3681 against Clostridium difficile strains. Anaerobe 28, pages 216-219.
Crossref
Crossref
Moran Shalev & Timor Baasov. (2014) When proteins start to make sense: fine-tuning of aminoglycosides for PTC suppression therapy. MedChemComm 5:8, pages 1092-1105.
Crossref
Crossref
Deepak Kumar, Beena, Garima Khare, Saqib Kidwai, Anil K. Tyagi, Ramandeep Singh & Diwan S. Rawat. (2014) Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation. European Journal of Medicinal Chemistry 81, pages 301-313.
Crossref
Crossref
Yong-Chul Jeong, Zsolt Bikadi, Eszter Hazai & Mark G. Moloney. (2014) A Detailed Study of Antibacterial 3-Acyltetramic Acids and 3-Acylpiperidine-2,4-diones. ChemMedChem, pages n/a-n/a.
Crossref
Crossref
Santi M. Mandal, Anupam Roy, Ananta K. Ghosh, Tapas K. Hazra, Amit Basak & Octavio L. Franco. (2014) Challenges and future prospects of antibiotic therapy: from peptides to phages utilization. Frontiers in Pharmacology 5.
Crossref
Crossref
M. Daben Libardo, Jorge L. Cervantes, Juan C. Salazar & Alfredo M. Angeles-Boza. (2014) Improved Bioactivity of Antimicrobial Peptides by Addition of Amino-Terminal Copper and Nickel (ATCUN) Binding Motifs. ChemMedChem, pages n/a-n/a.
Crossref
Crossref
Richard J. FairYitzhak Tor. (2014) Antibiotics and Bacterial Resistance in the 21st Century. Perspectives in Medicinal Chemistry 6, pages PMC.S14459.
Crossref
Crossref
Sunny Manohar, Antonella Pepe, Christian E. Vélez Gerena, Beatriz Zayas, Sanjay V. Malhotra & Diwan S. Rawat. (2014) Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids. RSC Advances 4:14, pages 7062.
Crossref
Crossref
Daniel N. Wilson. (2013) Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nature Reviews Microbiology 12:1, pages 35-48.
Crossref
Crossref
Yifat Berkov-Zrihen, Keith D. Green, Kristin J. Labby, Mark Feldman, Sylvie Garneau-Tsodikova & Micha Fridman. (2013) Synthesis and Evaluation of Hetero- and Homodimers of Ribosome-Targeting Antibiotics: Antimicrobial Activity, in Vitro Inhibition of Translation, and Drug Resistance. Journal of Medicinal Chemistry 56:13, pages 5613-5625.
Crossref
Crossref
Kristin J Labby & Sylvie Garneau-Tsodikova. (2013) Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Medicinal Chemistry 5:11, pages 1285-1309.
Crossref
Crossref
Stuart Shapiro. (2013) Speculative strategies for new antibacterials: all roads should not lead to Rome. The Journal of Antibiotics 66:7, pages 371-386.
Crossref
Crossref
Racheli Ben-Knaz, Rami Pedahzur & David Avnir. (2013) Bioactive doped metals: high synergism in the bactericidal activity of chlorhexidine@silver towards wound pathogenic bacteria. RSC Advances 3:21, pages 8009.
Crossref
Crossref
Yong-Chul Jeong, Muhammad Anwar, Zsolt Bikadi, Eszter Hazai & Mark G. Moloney. (2013) Natural product inspired antibacterial tetramic acid libraries with dual enzyme inhibition. Chem. Sci. 4:3, pages 1008-1015.
Crossref
Crossref
Gonzalo García, Isabel Serrano, Patricia Sánchez-Alonso, Manuel Rodríguez-Puyol, Ramón Alajarín, Mercedes Griera, Juan J. Vaquero, Diego Rodríguez-Puyol, Julio Álvarez-Builla & María L. Díez-Marqués. (2012) New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers. European Journal of Medicinal Chemistry 50, pages 90-101.
Crossref
Crossref
Salvatore Bongarzone, Hoang Ngoc Ai Tran, Andrea Cavalli, Marinella Roberti, Michela Rosini, Paolo Carloni, Giuseppe Legname & Maria Laura Bolognesi. (2011) Hybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts. ChemMedChem 6:4, pages 601-605.
Crossref
Crossref